United States · FDA National Drug Code directory
Hydrocodone Polistirex and Chlorpheniramine Polistirex extended-release
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 27808-086_b3ac95d4-bef9-4e32-9822-73b9534c9869
- Product NDC
- 27808-086
- Form
- SUSPENSION, EXTENDED RELEASE
- Composition / generic term
- Hydrocodone Polistirex and Chlorpheniramine Polistirex
- Labeler
- Cranbury Pharmaceuticals, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20150306
- Source listing expiry
- 20271231
Source-listed ingredients
- HYDROCODONE BITARTRATE — 10 mg/5mL
- CHLORPHENIRAMINE MALEATE — 8 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, UNIT-DOSE in 1 CARTON (27808-086-01) / 115 mL in 1 BOTTLE, UNIT-DOSE · 27808-086-01
- 473 mL in 1 BOTTLE (27808-086-02) · 27808-086-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →